Nadia Vancolard

Nadia Vancolard has worked in the clinical research field since 2010. Nadia began their career at Terumo Europe as a Clinical Trial Assistant where they were responsible for creating and maintaining databases, shipping medical material to investigational sites, maintaining stock levels of medical devices on site, device accountability, EC submission support, adverse event tracking and reporting to competent authorities, taking meeting minutes, filing according to SOPs, preparation of investigator site files, and data input for trials and registries. In 2014, they joined Chiltern International as a Sr. Regulatory Country Submission Specialist and Clinical Trial Administrator. In their role as Sr. Regulatory Country Submission Specialist, Nadia was responsible for managing study start-up activities such as identification of potential investigative sites, working with investigative sites to collect the required investigator and regulatory documents, regulatory and ethics submissions, and quality control through all phases of a clinical trial. In their role as Clinical Trial Administrator, Nadia was responsible for conducting country and site level feasibilities, assisting with clinical start-up activities, documenting and tracking all study activities, preparing ISF/PSF, and assisting the Project Manager/LCRA in organizing and attending study team meetings and investigator meetings. Most recently, in 2021, Nadia joined BIOSENIC S.A. as a Global Clinical Trial Manager and Clinical Research Coordinator. In their role as Global Clinical Trial Manager, Nadia was responsible for operational oversight of a phase II international trial, patient recruitment strategy establishment, liaising with investigators, vendor management, risk assessment, site feasibility assessment, site management, assisting vendors in motivational visits/site initiation visits, preparation and review of study plans and essential documents, and review monitoring visit reports. In their role as Clinical Research Coordinator, Nadia was responsible for therapeutic area/lab experience in Endocrinology - Phase II trial.

Nadia Vancolard obtained their Certification in Farmaceutische wetenschappen - Pathophysiology from Katholieke Universiteit Leuven in 2014. Prior to that, they studied Biomedische wetenschappen (Biomedical Sciences) at Katholieke Hogeschool Leuven from 2005 to 2007.